What we are seeing in the market.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Operator analysis of health markets in Europe, the US, and MENA: four monthly Vital Signs editions, the PROGNOSIS flagship, perspectives, and the reference work behind them.
Vital Signs · MedTech
A device can wait about two years between its first approval and its second, and the lead piece sets out what stretched the longest waits. This month's deals show what buyers paid for medtech companies, from $240 million to $2.1 billion, and what Stryker's $400 million in CMR Surgical buys it.
27 October 2026
Vital Signs · MedTechA device can wait about two years between its first approval and its second, and the lead piece sets out what stretched the longest waits. This month's deals show what buyers paid for medtech companies, from $240 million to $2.1 billion, and what Stryker's $400 million in CMR Surgical buys it.
Vital Signs · AI HealthcareThe FDA authorised two AI devices their makers may keep changing, and Medicare found no benefit category for a cleared device, so it pays nothing for it.
Vital Signs · MedTechTen companies took twelve European device certificates in ten days, and the three products that left European markets left because a manufacturer stopped trading, a board stopped funding, and a catheter specification failed.
Vital Signs · HealthTechTwo Swedish regions abandoned the same hospital record system after €630m. What worked instead was a nurse with a list and a posted letter.
Vital Signs · AI Drug DiscoveryAI drug discovery, September 2026: the AIntibody benchmark tested protein design methods blind, and ICH M15 now asks six questions of any model.
Vital Signs · HealthTechOracle, Microsoft and Athenahealth folded the AI scribe into the health record. Ontario tested twenty approved AI scribes and every one produced an error.
Vital Signs · MedTechMedTech's opening cycle shows devices clearing approval, then losing on reimbursement, vigilance, and evidence standards: three tests approval cannot predict.
Vital Signs · AI HealthcareThe EU moved the AI Act deadline for AI in medical devices to August 2028, but three obligation sets kept their original dates and are in force today.